Articles in PresS. J Neurophysiol (November 26, 2014). doi:10.1152/jn.00487.2014
1 2 3 4 5 6 7 8 9 10 11 12
HCN channels contribute to serotonergic modulation of ventral surface chemosensitive neurons and respiratory activity. Virginia E. Hawkins1*, Joanna M. Hawryluk1*, Ana C. Takakura2, Anastasios V. Tzingounis1, Thiago S. Moreira3, Daniel K. Mulkey1 1
Dept. of Physiology and Neurobiology, Univ. of Connecticut, Storrs, CT 06269, USA Dept. of Pharmacology, Univ. of Sao Paulo, Sao Paulo, SP, 05508, Brazil; 3 Dept. of Physiology and Biophysics, Univ. of Sao Paulo, Sao Paulo, SP, 05508, Brazil 2
13
* V. H. and J. M. H. contributed equally to this work.
14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Address of corresponding authors: Daniel K. Mulkey Dept. Physiology and Neurobiology University of Connecticut 75 N. Eagleville Rd. Unit 3156 Storrs, CT 06269
[email protected] 860 486 5700 860 486 3303
37 38 39 40 41
ACKNOWLEDGMENTS This work was supported by funds from the National Institutes of Health Grants HL104101 (DKM) and NS073981 (AVT) and public funding from the São Paulo Research Foundation (FAPESP) grants 09/54888-7, 13/10573-8 (TSM) and 10/09776-3 (ACT).
Virginia E. Hawkins Dept. Physiology and Neurobiology University of Connecticut 75 N. Eagleville Rd. Unit 3156 Storrs, CT 06269
[email protected] 860 486 5572 860 486 3303
Abbreviated Title: Ih contributes to serotonergic modulation of breathing Keywords: retrotrapezoid nucleus, serotonin; 5-HT7, cAMP, Gs-coupled receptor Abstract Introduction Discussion Total including references Number of figures: Number of pages:
248 517 1149 8674 7 37
42 43
1
Copyright © 2014 by the American Physiological Society.
44
ABSTRACT
45
Chemosensitive neurons in the retrotrapezoid nucleus (RTN) provide a CO2/H+-dependent
46
drive to breathe and function as an integration center for the respiratory network, including
47
serotonergic raphe neurons.
48
chemoreceptors involved inhibition of KCNQ channels and activation of an unknown inward
49
current. HCN channels are the molecular correlate of the hyperpolarization-activated inward
50
current (Ih) and have a high propensity for modulation by serotonin. To investigate whether
51
HCN channels contribute to basal activity and serotonergic modulation of RTN
52
chemoreceptors, we characterize resting activity and effects of serotonin on RTN
53
chemoreceptors in vitro, and on respiratory activity of anesthetized rats in the presence or
54
absence of blockers of KCNQ (XE991) and/or HCN (ZD7288, Cs+) channels. We found in
55
vivo that, bilateral RTN injections of ZD7288 increased respiratory activity, and in vitro HCN
56
channel blockade increased activity of RTN chemoreceptors under control conditions but this
57
was blunted by KCNQ channel inhibition. Furthermore, in vivo, unilateral RTN injection of
58
XE991 plus ZD7288 eliminated the serotonin response and in vitro, serotonin-sensitivity was
59
eliminated by application of XE991 and ZD7288 or SQ22536 (adenylate cyclase blocker).
60
Serotonin-mediated activation of RTN chemoreceptors was blocked by a 5-HT7-receptor
61
blocker and mimicked by a 5-HT7-receptor agonist.
62
depolarizing-shift in the voltage-dependent activation of Ih. These results suggest that HCN
63
channels contribute to resting chemoreceptor activity, and that serotonin activates RTN
64
chemoreceptors and breathing in part by a 5-HT7 receptor-dependent mechanism and
65
downstream activation of Ih.
We recently showed that serotonergic modulation of RTN
In addition, serotonin caused a
66 67 68
2
69
INTRODUCTION
70
Central chemoreception is the mechanism by which the brain regulates breathing in response
71
to changes in CO2/H+. A region of the brainstem called the retrotrapezoid nucleus (RTN) is
72
an important site of chemoreception. Neurons (Wang et al. 2013) and astrocytes (Gourine et
73
al. 2010) in this region sense changes in CO2/H+ to produce an integrated CO2/H+-dependent
74
drive to breathe. Chemosensitive RTN neurons also integrate respiratory drive from other
75
regions of the respiratory circuit such as serotonergic raphe neurons (Mulkey et al. 2007).
76
Serotonin is a potent modulator of breathing (Richerson 2004; Corcoran et al. 2014),
77
including at the level of the RTN, where serotonin has been shown to stimulate
78
chemoreceptor activity in vitro and increase breathing in conscious and anesthetized animals
79
(Hawryluk et al. 2012). In addition, disruption of serotonergic signaling has been shown to
80
decrease the respiratory chemoreflex (Hodges et al. 2008; Ray et al. 2011) and may
81
contribute to respiratory failure associated with sudden unexpected death in epilepsy
82
(SUDEP) (Massey et al, 2014; Buchanan et al., 2014). Despite this critical physiological
83
role, mechanisms by which serotonin activates RTN chemoreceptors have yet to be fully
84
elucidated.
85 86
Serotonergic signaling is mediated through seven receptor families (5-HT1-7), including Gi
87
(5-HT1), Gq-(5HT2) and Gs- (5HT4,7) coupled receptors (Richter et al. 2003). In the RTN,
88
serotonin sensitivity can be blocked with ketanserin (Mulkey et al. 2007), an antagonist for
89
both 5-HT2 and 5-HT7 receptors (Beique et al. 2004; Jasper et al. 1997). Evidence also
90
indicates that serotonergic modulation of RTN neurons is determined, in part, by inhibition of
91
KCNQ channels (Hawryluk et al. 2012), most likely by a 5-HT2 Gq-coupled receptor
92
mechanism (Mulkey et al. 2007; Delmas and Brown 2005). However, RTN chemoreceptors
93
retain approximately half their serotonin sensitivity when KCNQ channels are blocked,
3
94
suggesting involvement of other channels. Preliminary data suggests that when KCNQ
95
channels are blocked, serotonin sensitivity of RTN neurons can be eliminated by inhibiting
96
hyperpolarization-activated cyclic-nucleotide-gated (HCN) channels (Hawryluk et al. 2012),
97
which produce a hyperpolarization-activated inward current (Ih). HCN channels are known
98
to be activated by cAMP (DiFrancesco and Totora 1991) and Gs-coupled receptor signaling
99
(Ulens and Tytgat 2001).
100
Therefore, we hypothesize that HCN channels contribute to
serotonergic modulation of RTN chemoreceptors.
101 102
Here, we demonstrate the functional presence of both KCNQ and HCN channels in RTN
103
chemoreceptors neurons. We show that inhibition of HCN channels increases ventilation in
104
vivo and the firing rate of RTN chemoreceptors under control conditions, but not when Ca2+
105
channels or other Cd2+-sensitive currents are blocked (Abbruzzese et al., 2010), suggesting
106
that HCN channels dampen basal chemoreceptor excitability by a Cd+2-sensitive mechanism
107
that may involve voltage-dependent Ca2+ channels, as described in other brain regions (Tsay
108
et al. 2007). Inhibition of HCN channels also blunted serotonergic modulation of RTN
109
neurons in vitro, and attenuated the ventilatory response to serotonin in vivo. During HCN
110
and KCNQ blockade, serotonin failed to stimulate chemoreceptor activity or breathing,
111
suggesting that coordinated activity of these channels is entirely responsible for serotonergic
112
modulation of RTN chemoreceptors. Further, inhibition of adenylate cyclase blocked the Ih
113
component of the serotonergic response in RTN chemoreceptors, suggesting involvement of a
114
GS-coupled receptor signaling. Consistent with this, serotonin-mediated activation of RTN
115
chemoreceptors was blocked with a 5-HT7-receptor blocker and mimicked by a 5-HT7-
116
receptor activator. We also find that serotonin shifted the voltage-dependence of Ih
117
activation to more depolarized potentials. These results build on our understanding of the
118
mechanisms by which serotonin regulates breathing by identifying a novel role of HCN
4
119
channels and 5-HT7 receptors in the serotonergic modulation of RTN chemoreceptors.
120
Furthermore, considering that HCN and KCNQ are epilepsy associated ion channels and
121
disruption of serotoninergic signaling may contribute to SUDEP, these results suggest that
122
HCN and KCNQ channels are common substrates for respiratory dysfunction and epilepsy.
123 124
METHODS
125
Animals
126
Animal use was in accordance with guidelines approved by the Universities of Connecticut
127
and São Paulo Institutional Animal Care and Use Committees. The in vivo experiments were
128
performed on male Wistar rats weighing 250-300 g (8-10 months old). In vitro experiments
129
were performed on brain slices isolated from rat pups (7-12 days postnatal).
130 131
In vivo preparation
132
The surgical procedures and experimental protocols were done as described previously
133
(Hawryluk et al. 2012). Briefly, general anesthesia was induced with 5% halothane in 100%
134
O2. Artificial ventilation with 1.4-1.5% halothane in 100% O2 was maintained throughout
135
surgery. Standard surgical procedures (bilateral vagotomy, arterial cannulation, phrenic nerve
136
dissection, and dorsal transcerebellar access to the ventrolateral medulla oblongata) were
137
used. After surgery, halothane was gradually replaced by urethane (1.2 g/kg, administered i.v.
138
over 20 min). This initial dose was supplemented hourly and at least twice with additional
139
urethane injections of 0.1 g/kg. After a total of 1.4-1.5 g/kg, the level of anesthesia was stable
140
for the duration of the experiment (up to 4 hours after initial anesthetic crossover). Rats were
141
ventilated with 100% O2 throughout the experiment and muscle relaxation was performed
142
with pancuronium (1 mg/kg i.v.). Rectal temperature was maintained at 37°C, and end-tidal
143
CO2 was monitored with a microcapnometer. The adequacy of anesthesia was continually
5
144
monitored by testing for the absence of arterial pressure or phrenic nerve discharge (PND)
145
responses to firm toe or tail pinch. After these criteria were satisfied, the muscle relaxant
146
pancuronium was administered i.v. at an initial dose of 1 mg/kg, and the adequacy of the
147
anesthesia was thereafter gauged by the lack of cardiorespiratory responses to a firm toe
148
pinch.
149
In vivo recordings of physiological parameters
150
As described (Mulkey et al. 2004), mean arterial pressure (MAP) and PND were digitized
151
with a Micro 1401 (Cambridge Electronic Design), stored on a computer, and processed off-
152
line with Spike 2 software. Integrated PND (iPND) was obtained after rectification and
153
smoothing (τ = 0.015 s) of the original signal, which was acquired with a 30-300 Hz
154
bandpass filter. PND amplitude, frequency and the product of PND frequency and amplitude
155
(i.e., the neural equivalent of minute ventilation) were expressed for each animal on a scale
156
ranging from 0 (value during apnea) to 100 (value while breathing 10% CO2).
157 158
Hypercapnia was produced by addition of pure CO2 to the 100% O2 supplied by artificial
159
ventilation to increase the maximum end-expiratory CO2 to 9.5–10%. End-expiratory CO2
160
was maintained for 5 min, and CO2 was removed. The level of CO2 required to stimulate
161
breathing was identified by increasing inspired CO2 in a stepwise fashion (Δ 1%) from 2-3%
162
up to 9-10% (5 min per step), and PND was measured during the last 30 s of each step when
163
end-expiratory CO2 and PND appeared to have reached equilibrium. The CO2 PND threshold
164
was determined as the % CO2 that first elicited PND. End-expiratory CO2 was measured by
165
averaging the maximum values recorded from 50 consecutive breaths at the midpoint of the
166
time interval sampled. One arbitrary unit represents the highest value of PND measured at
167
steady state with end-expiratory CO2 set at 9.5–10%.
168
6
169
Serotonin was injected by pressure (40–60 psi, 4 msec pulses, 50 nl in 3–5 sec) through glass
170
pipettes (20 μm outside diameter) filled with 1 mM serotonin creatinine sulfate in a pH 7.3
171
normal saline solution containing 1% (v/v) fluorescent microbeads (for histological
172
verification of injection sites). The concentration of serotonin used in these experiments was
173
based on the EC50 response elicited by serotonin injections into the hypoglossal nucleus of
174
anesthetized rats (Fenik and Veasey 2003). The pipette tip was placed 200 μm ventral to the
175
caudal edge of the facial motor nucleus under electrophysiological guidance as described
176
below for drug injections. In all cases, correct injection was verified by post-mortem
177
histological inspection of the location of fluorescent microbeads (Lumafluor, New City, NY).
178 179
Histology
180
At the end of each in vivo experiment, rats were deeply anesthetized with halothane and
181
perfused through the heart with PBS, pH 7.4, followed by paraformaldehyde (4% in 0.1 M
182
phosphate buffer, pH 7.4). The brains were removed and the medulla cut into 40-μm-thick
183
coronal sections (Vibratome 1000S Plus). We confirmed that injection sites were located
184
within the RTN by fluorescent visualization using an Axioskop 2 microscope (Carl Zeiss,
185
Thornwood, NY). Sections from different brains were aligned with respect to a reference
186
section, which was the most caudal section containing an identifiable cluster of facial motor
187
neurons. This reference section was assigned a value of 11.6 mm caudal to bregma (bregma: -
188
11.6 mm; Paxinos and Watson 1989).
189 190
Brain slice preparation and slice-patch electrophysiology
191
As described (Mulkey et al. 2004; Wenker et al. 2012b), neonatal rats (P7-12 days postnatal)
192
were decapitated under ketamine/xylazine anesthesia, and transverse brainstem slices (300
193
μm) were cut using a microslicer (DSK 1500E; Dosaka) in ice-cold substituted Ringer
7
194
solution containing (in mM): 260 sucrose, 3 KCl, 5 MgCl2, 1 CaCl2, 1.25 NaH2PO4, 26
195
NaHCO3, 10 glucose, and 1 kynurenic acid. Slices were incubated for ∼30 min at 37°C and
196
subsequently at room temperature in normal Ringer solution (in mM): 130 NaCl, 3 KCl, 2
197
MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 glucose. All solutions were equilibrated
198
with 95% O2-5% CO2, extracellular pH 7.35.
199 200
Individual slices containing the RTN were transferred to a recording chamber mounted on a
201
fixed-stage microscope (Zeiss Axioskop FS) and perfused continuously (∼2 ml min−1) with
202
normal Ringer solution bubbled with 95% O2-5% CO2. Hypercapnic solution was made by
203
equilibrating normal Ringer solution with 15% CO2 balance O2 (pHo ~6.90). All recordings
204
were made from neurons located within 100 µm of the ventral surface and below the caudal
205
end of the facial motor nucleus using an Axopatch 200B patch-clamp amplifier, digitized
206
with a Digidata 1322A A/D converter, and recorded using pCLAMP 10.0 software
207
(Molecular Devices, Sunnyvale, CA). Recordings were obtained at room temperature
208
(∼22°C) with electrodes pulled from borosilicate glass capillaries (Harvard Apparatus,
209
Hamden, CT) on a two-stage puller (P89; Sutter Instrument) to a DC resistance of 5–7 MΩ
210
when filled with an internal solution containing (in mM): 120 KCH3SO3; 4 NaCl; 1 MgCl2;
211
0.5 CaCl2; 10 HEPES; 10 EGTA; 3 Mg-ATP; and 0.3 GTP-Tris (pH 7.2), electrode tips were
212
coated with Sylgard 184 (Dow Corning Corporation, Midland, MI). All recordings of firing
213
rate were performed using the cell-attached configuration and firing rate histograms were
214
generated by integrating action potential discharge in 10 sec bins and plotted using Spike 5.0
215
software. Whole cell current-clamp recordings were made using internal solution containing
216
(in mM): 125 potassium gluconate; 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; 4
217
Mg-ATP; 0.3 Na-GTP; 0.1 EGTA; 10 2-Tris-phosphocreatine and 0.05% biocytin (pH 7.3).
218
Cells were held at -60 mV and depolarizing steps from -100pA were applied (Δ +10 mV).
8
219
Input resistance (Rin) was calculated from the voltage responses to hyperpolarizing steps.
220
Initial spike frequency was measured following a 50 pA current injection and the rebound
221
spike latency taken as the mean time to first action potential following hyperpolarizing steps
222
(-100 to -70 pA). The sag ratio was expressed as [(1-∆Vss/∆Vmin) x 100%], where ∆Vss =
223
resting membrane potential (RMP) - Vss, ∆Vmin = RMP – Vmin, RMP is the resting membrane
224
potential, Vs is the steady state potential and Vmin is the initial minimum potential. Voltage-
225
clamp recordings were made at a holding potential of -60 mV and in the presence of
226
tetrodotoxin (TTX; 0.5 μM; Alomone Labs) to block action potentials and barium (1 mM) to
227
block leak K+ channels.
228
relationships were determined by applying hyperpolarizing voltage steps from -60 to -150
229
mV for 1000 ms (Δ -10 mV). The maximal amplitude of Ih was quantified as the size of the
230
time-dependent current during a step to -150 mV. The voltage dependence of Ih activation
231
was obtained from tail currents measured at -70 mV following a series of hyperpolarizing
232
steps; those data were normalized, plotted as a function of the initial step potential, and fitted
233
to a Boltzmann function for calculation of voltage for half-maximal activation (V50) of Ih.
234
For whole cell recordings series resistance (Ra) was typically 10% during an experiment.
Holding current, conductance, and current–voltage (I–V)
237 238
Drugs
239
All drugs were purchased from Tocris Bioscience unless otherwise stated. For in vivo
240
experiments, the KCNQ channel blocker XE991 (Abcam Biochemicals, Cambridge, MA)
241
and the HCN channel blocker ZD7288 (Sigma-Aldrich) were diluted to 50 µM in sterile
242
saline (pH 7.4) and injected into the RTN using a single-barrel glass pipette (tip diameter of
243
20 µm) connected to a pressure injector (Picospritzer III, Parker Hannifin Corp, Cleveland,
9
244
OH). Since the RTN is located bilaterally and both structures contribute to the chemoreflex,
245
to test for contributions of KCNQ and HCN channels to the CO2/H+-drive to breathe we
246
injected XE991 or ZD7288 bilaterally. However, since unilateral RTN injection of serotonin
247
can elicit a ventilatory response, we also tested contributions of KCNQ and HCN to this
248
response by making same side injections of the blockers. For each injection we delivered a
249
volume of 50 nl over a period of 5s. These glass pipettes also allowed for recordings of field-
250
potential properties that were used to help direct the electrode tip to the desired site.
251
Injections in the RTN region were guided by recordings of the facial field potential (Brown
252
and Guyenet 1985), and were placed 250 μm below the lower edge of the field, 1.7 mm
253
lateral to the midline, and 200 μm rostral to the caudal end of the field. Recordings were
254
made on one side only; the second injection was made 1-2 min later at the same level on the
255
contralateral side. We included a 2% dilution of fluorescent latex microbeads with all drug
256
applications to mark the injection sites and verify the spread of the injections (Takaura and
257
Moreira 2011; Takakura et al. 2011). For in vitro experiments, we bath-applied serotonin
258
hydrochloride (5 µM, Sigma-Aldrich), XE991 (10 µM, Abcam Biochemicals) to block
259
KCNQ channels, ZD7288 (50µM) or CsCl (2mM, Sigma-Aldrich) to block HCN channels,
260
CdCl2 (100 µM, Sigma-Aldrich) to block voltage-gated calcium channels, synaptic block
261
perfusate contained kynurenic acid (1 mM, Sigma-Aldrich) to block ionotropic glutamate
262
receptors, bicuculline (10 µM, Sigma-Aldrich) to block GABAA receptors and strychnine (20
263
µM, Sigma-Aldrich) to block glycine receptors, SQ22536 (100 µM) to inhibit adenylate
264
cyclase activity, SB258719 (10 µM) to block 5-HT7 receptors, 5-carboxamidotryptamine (5-
265
CT, 5 µM) to activate 5-HT7 as well as several Gi-coupled receptors (i.e., 5-HT1A/1B/1D/5),
266
WAY100635 (0.1 µM) to block 5-HT1A receptors and the specific 5-HT7 agonist LP-44 (2
267
uM).
268
10
269
Statistical Analysis
270
Data are reported as mean ± standard error of the mean. Statistical analysis was performed
271
using GraphPad Prism version 3.0 software. Data was assessed for normality and the student
272
t-test or one-way ANOVA followed by Newman-Keuls multiple-comparisons test were used
273
as appropriate. The relevant values used for statistical analysis are provided in the results
274
section.
275 276
RESULTS
277
This study consists of three sets of experiments designed to address the mechanistic
278
underpinnings of serotonin-induced respiratory activity in the RTN. First, to determine if
279
serotonin-mediated cardiorespiratory control within the RTN involves HCN channels, we
280
examined breathing and blood pressure in anesthetized rats injected with serotonin into the
281
RTN, either alone or after injection of KCNQ and/or HCN channel blockers.
282
channels were blocked in a number of experiments to reveal the KCNQ independent
283
component to the serotonin response. Second, to determine whether HCN channels regulate
284
excitability and serotonergic modulation of RTN chemoreceptors we tested effects of
285
blocking HCN channels, alone and during blockade of KCNQ channels, on RTN neuron
286
activity (basal firing rate and serotonin-sensitivity) in the brain slice preparation.
287
identify mechanism(s) underlying serotonergic modulation of HCN channels in RTN
288
chemoreceptors, we assessed serotonin responses when adenylate cyclase activity is blocked,
289
and tested the effects of subtype-specific serotonin receptor modulators on RTN
290
chemoreceptor activity.
291
effects of serotonin on amplitude and voltage-dependent activation of Ih.
KCNQ
Third, to
Furthermore, in voltage-clamp experiments, we determined the
292
11
293
Here we focus on chemosensitive RTN neurons which have been shown to express the
294
transcription factor Phox2b (Lazarenko et al. 2009; Stornetta et al. 2006). However, Phox2b
295
is also expressed by other cells in relatively close proximity to the RTN, including
296
catecholaminergic neurons (C1 and A5), facial motor neurons, and the superior salivatory
297
nucleus (Kang et al. 2007). Therefore, we chose to functionally identify CO2/H+-sensitive
298
RTN neurons based on their characteristic firing rate response to CO2/H+. Neurons were
299
considered chemosensitive if they increased firing rate by ≥ 1.5 Hz following exposure to
300
15% CO2. This level of CO2/H+ response is similar to what we, and others, have reported for
301
chemosensitive RTN neurons in vitro (Mulkey et al. 2006; Ritucci et al. 2005; Wenker et al.
302
2010). RTN neurons that did not exhibit this minimum response were considered non-
303
chemosensitive and excluded from this study.
304 305 306 307 308
HCN channels in the RTN contribute to basal activity and serotonergic modulation of respiratory drive
309
modulation of RTN neurons (Hawryluk et al. 2012). Preliminary in vitro evidence also
310
suggested that HCN channels are expressed in RTN neurons and contribute to serotonin
311
responses (Hawryluk et al. 2012). To establish the functional significance of HCN channels
312
in controlling breathing, we tested whether RTN injection of an HCN channel blocker
313
(ZD7288) affects resting respiratory motor output of anesthetized rats.
314
whether the ventilatory response to serotonin was altered by RTN injection of ZD7288. All
315
injections (uni- or bilateral) were placed 250 µm below the facial motor nucleus and 200 µm
316
rostral to the caudal end of this nucleus to target the region containing the highest density of
317
CO2-sensitive RTN neurons (Mulkey et al. 2004; Takakura and Moreira 2011; Takakura et al.
318
2011) (Figs. 1E and 2B).
Previous evidence indicates that KCNQ channels regulate activity and serotonergic
We then tested
319 12
320
In anesthetized animals, we found that bilateral RTN injections of ZD7288 (50 µM, 50 nl
321
each side) increased resting respiratory output as measured by a change in phrenic nerve
322
discharge, PND. As described previously, bilateral injections of XE991 into the RTN
323
increased the neural equivalent of minute ventilation (mvPND, product of PND amplitude
324
and frequency) (Fig. 1B,E). Bilateral injections of ZD7288 to inhibit HCN channels also
325
increased respiratory activity by 48 ± 7% (F(3,56) = 144.12, p 0.05). However,
330
bilateral application of XE991 and/or ZD7288 shifted the CO2 threshold (i.e., the level of
331
CO2 required to stimulate ventilatory output) from 5.3 ± 0.09 to 4.5 ± 0.1% (F(3,56) = 87.44, p
332
< 0.01) (Fig. 1D). These data suggest that inhibition of KCNQ and HCN channels increases
333
excitability of RTN chemoreceptors and consequently the respiratory system responses to
334
changes in CO2.
We also found that the
335 336
In agreement with previous studies (Hawryluk et al. 2012; Mulkey et al. 2007), unilateral
337
RTN injection of serotonin (1 mM) increased PND amplitude by 37 ± 5% above baseline (F(3,
338
29)=
339
unilateral RTN injection of XE991 (50 μM, 50 nl) or the HCN blocker ZD7288 (50 µM, 50
340
nl) had no discernible effect on resting PND (F(3, 29)= 0.011, p > 0.05; Fig. 2A). However,
341
injection with either channel blocker significantly blunted—and together essentially
342
eliminated—serotonin modulation of respiratory activity (Figs. 2A, C).
343
injection of serotonin after application of either XE991 (Fig. 2A1) or ZD7288 (Fig. 2A2)
344
only increased PND amplitude 22 ± 2% and 29 ± 3% above baseline, respectively. This
129.83, p < 0.01; Figs. 2A, C). After respiratory activity returned to control levels,
For example,
13
345
reflects a 40 ± 3% and 21 ± 2% decrease in serotonin responsiveness, respectively, relative to
346
control conditions (F(3,29) = 167.74, p 0.05; Fig. 2A, summary data not shown), suggesting that
351
KCNQ and HCN channels are not involved in cardiovascular regulation at this level of the
352
rostral ventrolateral medulla. These results demonstrate that KCNQ channels and HCN
353
channels within the RTN serve as functional determinants of serotonergic modulation of
354
respiratory drive.
355 356 357 358 359
HCN channels contribute to both resting firing behavior and serotonergic modulation of RTN chemoreceptors in vitro
360
characterized membrane potential responses to hyperpolarizing and depolarizing current steps
361
under control conditions and during HCN channel blockade. In the whole-cell current-clamp
362
configuration, chemosensitive RTN neurons have an Rin of 910 ± 83MΩ and exhibit a sag
363
ratio of 32.3 ± 4.6 % in response to a -100 pA hyperpolarizing voltage step (Fig. 3A). At the
364
end of the hyperpolarizing step chemosensitive RTN neurons produce a rebound spike with a
365
latency of 109 ± 19 ms (Fig. 3A4). Bath application of ZD7288 (50µM) increased Rin to
366
1196.0 ± 64.5 MΩ, eliminated the sag (to a sag ratio of only 3.1 ± 4.5 %) (T(5) = 5.96, p =
367
0.0019; Fig. 3A2), and increased the rebound spike latency (T(5) = 3.68, p = 0.0142; Fig.
368
3A4). We also found that the firing rate response to a depolarizing current injection (20 pA)
369
was unaffected by ZD7288 (Fig. 3A3). This is not surprising considering that HCN channels
370
are inhibited by depolarization. Furthermore, blocking KCNQ channels with XE991 (10µM)
371
caused a modest increase in Rin (T(4) = 4.71, p = 0.0093) but with no effect on the sag
To examine the contribution of HCN channels to activity of RTN chemoreceptors, we first
14
372
potential or rebound spike latency (Figs. 3B).
373
instantaneous spike frequency elicited by 20 pA current injections (Fig. 3B4). These results
374
indicate that HCN and KCNQ channels regulate intrinsic electrical properties of
375
chemosensitive RTN neurons.
In addition, XE991 also increased the
376 377
Next, to determine whether HCN channels regulate excitability of RTN chemoreceptors, we
378
tested the effects of HCN channel blockers (ZD7288 or Cs+) on basal activity in the rat
379
brainstem slice preparation. We also used HCN channel blockers alone and in conjunction
380
with XE991 to test for contributions of HCN channels to the serotonin response of RTN
381
chemoreceptors. We found that under control conditions, inhibition of HCN channels with
382
ZD7288 (50 µM) or Cs+ (2 mM) increased chemoreceptor activity by 1.01 ± 0.17 Hz (T(16) =
383
5.93, p < 0.0001; Figs. 4A,B), suggesting that HCN channels can limit basal activity of RTN
384
chemoreceptors.
385
chemoreceptor activity (T(15) = 1.497, p = 0.1551) so data was pooled.
386
from other brain regions, HCN channels may inhibit neural activity by shunting synaptic
387
potentials (Stuart and Spruston 1998) or by influencing activity of other voltage-dependent
388
channels including KCNQ (George et al. 2009) and Ca2+ channels (Tsay et al. 2007). To
389
determine which of these possibilities may contribute to the inhibitory effects of HCN
390
channel on resting activity of RTN chemoreceptors, we characterized effects of HCN channel
391
blockade i) when excitatory and inhibitory receptors are blocked with a cocktail containing
392
kynurenic acid (1 mM), bicuculline (10 µM) and strychnine (20 µM) (i.e., synaptic
393
blockade); ii) when KCNQ channels were blocked with XE991, and iii) when voltage-gated
394
Ca2+ channels were blocked with Cd2+ (100 µM). We found that the firing rate response of
395
RTN chemoreceptors to HCN channel blockade (i.e., bath application of ZD7288 or Cs+) was
396
unaffected by synaptic blockade but was reduced to a change of 0.38 ± 0.16 Hz in XE991 and
Note that there was no difference in effects of ZD7288 and Cs+ on Based on evidence
15
397
eliminated (0.08 ± 0.06 Hz) in Cd2+ (F(3,39) = 7.13, p = 0.0006; Fig. 4A,B), suggesting that
398
HCN channels limit basal activity of RTN chemoreceptors indirectly by mechanisms
399
involving KCNQ and Cd+2-sensitive channels including Ca2+ channels.
400 401
As expected, bath application of serotonin (5 µM) increased activity of these cells by 1.18 ±
402
0.13 Hz (paired T(14) = 9.00, p < 0.001; Figs. 4A,C) and it did so in a reversible and
403
repeatable manner (ratio of the third serotonin response divided by the second response was
404
0.9 ± 0.1; Hawryluk et al. 2012). Bath application of XE991 (10 µM) to block KCNQ
405
channels increased baseline firing by 1.04 ± 0.43 Hz (paired T(10) = 5.42, p = 0.0003) and
406
blunted serotonin-responsiveness by 54.3 ± 11.9% (F(3,38) = 20.06, p < 0.0001; Figs. 4A,C), as
407
previously reported (Hawryluk et al. 2012). Application of ZD7288 (50µM) to block HCN
408
channels (with DC current injection to adjust baseline to control levels) reduced subsequent
409
serotonin response to an increase of only 0.57 ± 0.09 Hz (Fig. 4A,C). Notably, when both
410
KCNQ and HCN channels are blocked with XE991 and ZD7288 or Cs+ (with baseline
411
activity adjusted by DC current injection to near control levels), serotonin increased firing
412
rate less than under control conditions (Figs. 4A, C), i.e., serotonin increased activity by only
413
0.11 ± 0.04 Hz in XE991 plus ZD7288 and only 0.07 ± 0.17 Hz in XE991 plus Cs+ . When
414
the inhibitory contribution of HCN channel activity was blocked by Cd2+, exposure to
415
serotonin stimulated chemoreceptor activity by an amount similar to that of control
416
conditions (T(5) = 0.66; p = 0.5407; Figs 4A2,F), as expected for activation of an inward
417
depolarizing current. It should be noted that CO2/H+-sensitivity of RTN neurons was retained
418
when HCN channels were blocked with ZD7288 or Cs+ (Figs 4D, E). These results suggest
419
that both KCNQ and HCN channels are essential components of serotonergic modulation in
420
RTN chemoreceptor neurons. Collectively these results also suggest that the net contribution
421
of HCN channels to RTN chemoreceptor basal activity is to limit excitability indirectly by
16
422
influencing activity of KCNQ and Ca2+ channels.
423
presumably a select subset of HCN channels by serotonin can increase chemoreceptor
424
activity and contribute to the excitatory effects of serotonin on breathing.
However, targeted activation of
425 426 427 428 429
Serotonin activates Ih in RTN neurons by a Gs-coupled receptor and cAMP-dependent mechanism
430
KCNQ and HCN channels. HCN channels are known to be activated by Gs-coupled receptors
431
(Ulens and Tygat 2001) but inhibited by Gq-coupled receptor signaling (Lui et al. 2003),
432
indicating that HCN channel activity may be regulated by diverse signal transduction
433
pathways. Gs-coupled receptor signaling involves activation of adenylate cyclase and
434
increased cAMP production (Wettschureck and Offermanns 2005), and it is well known that
435
cAMP can directly bind HCN channels to facilitate Ih (DiFrancesco et al. 1991).
436
therefore tested the possibility that serotonin activates HCN channels by Gs-coupled receptor
437
signaling.
It is unlikely that a single serotonin receptor subtype mediates these divergent effects on
We
438 439
We first sought to determine if adenylate cyclase activity is required for serotonin-mediated
440
activation of Ih. To study serotonin modulation of HCN channels in relative isolation, we
441
performed these experiments in the presence of XE991 (10 µM) to block KCNQ channels.
442
As before, KCNQ channel blockade decreased the firing rate response to serotonin (control,
443
1.34 ± 0.21 Hz; XE991, 0.81 ± 0.22 Hz) (F(2,4) = 11.38, p = 0.0046; Figs. 5A, C). During
444
KCNQ channel blockade (and after baseline activity was adjusted by DC current injection to
445
near control levels) application of the adenylate cyclase inhibitor SQ22536 (100 µM)
446
increased the firing rate of RTN chemoreceptors by 0.80 ± 0.70 Hz (T(4) = 6.43, p = 0.0030;
447
Figs. 5A, B). However, when HCN channels are blocked with Cs+ (2 mM), bath application
448
of SQ22536 still increase in chemoreceptor activity by an amount similar to under control 17
449
conditions (N=3; data not shown), suggesting cAMP can modulate activity of RTN
450
chemoreceptors by mechanisms in addition to activation of HCN.
451
presence of SQ22536 inhibition of HCN with Cs+ increased RTN chemoreceptor activity by
452
an amount similar to under control conditions (N=4; data not shown), suggesting that cAMP
453
is not required for the maintenance of HCN channel activity under basal conditions. This
454
later finding is consistent with the possibility that the inhibitory contribution of HCN to basal
455
activity of RTN neurons is determined indirectly by the voltage dependent modulation of
456
KCNQ and Ca2+ channels. Nevertheless, in the presence of XE991 and SQ22536, exposure
457
to serotonin increased firing rate by only 0.25 ± 0.06 Hz (F(2,4) = 11.38, p = 0.0046; Figs. 5A,
458
C). These findings suggest that adenylate cyclase activity is required for the Ih component of
459
serotonergic modulation of chemosensitive RTN neurons.
Furthermore, in the
460 461
In other brain regions, cAMP-mediated activation of HCN channels results from a
462
depolarizing shift in voltage-dependent activation of Ih (DiFrancesco and Totora 1991). To
463
confirm this is the case for RTN chemoreceptors, we characterized effects of serotonin on the
464
maximum amplitude and voltage-dependent activation of Ih. Maximum Ih amplitude was
465
defined as the difference between instantaneous and steady-state currents during a -150 mV
466
step (represented in Fig 6A by dashed lines). In the whole-cell voltage-clamp configuration
467
(holding potential of -60 mV and in TTX [0.5 µM] to block action potentials), Ih was
468
detected by its characteristic time-dependent activation during hyperpolarizing voltage steps.
469
The maximum amplitude of Ih in RTN chemoreceptors was 64.55 ± 14.53 pA under control
470
conditions and 57.1 ± 12.5 pA during exposure to serotonin (Fig. 6B). In addition, bath
471
application of ZD7288 largely eliminated Ih (F(2,21) = 5.21, p = 0.0146; Fig. 6B). These
472
results suggest that serotonin does not affect maximum Ih in these cells.
473
18
474
To determine the effects of serotonin on the voltage dependency of Ih activation we measured
475
tail currents at a fixed potential of -70 mV under control conditions and after activating Ih
476
with a series of hyperpolarizing voltage steps. Normalized Ih tail currents were plotted as a
477
function of membrane potential during the initial hyperpolarizing steps and fitted with a
478
Boltzmann function to determine the half-activation voltage (V1/2) (Sirois et al. 2002; Wenker
479
et al. 2012a). The V1/2 for Ih activation averaged -120.1 ± 3.2 mV in control conditions and -
480
103.7 ± 6.0 mV in serotonin (T(4) = 2.35, p = 0.0394; Fig. 6C), indicating that serotonin
481
caused a depolarizing shift of ~16 mV in the voltage-dependent activation of Ih. These
482
results demonstrate Ih within RTN chemoreceptor neurons and strongly suggest that
483
serotonin activates HCN channels in the RTN by a Gs- and cAMP-dependent mechanism.
484 485
Several members of the serotonin receptor family are Gs-coupled including 5-HT4, 5-HT6
486
and 5-HT7. Of these, 5-HT7 receptors in particular are inhibited by ketanserin (Lesage et al.
487
1998; Shen et al. 1993). Since ketanserin was shown to block the serotonin responses of
488
chemosensitive RTN neurons (Mulkey et al. 2007), we considered the possibility that 5-HT7
489
receptors mediate the effects of serotonin on Ih. To test for involvement of 5-HT7 receptors,
490
we used 5-CT, which activates 5-HT7 as well as several Gi-coupled receptors (i.e., 5-
491
HT1A/1B/1D/5), and WAY100635, which selectively blocks 5-HT1A receptors (Beique et al.
492
2004). If exposure to 5-CT mimicked effects of serotonin on chemoreceptor activity under
493
control and WAY100635-exposed conditions by a Ih-dependent mechanism, this would
494
suggest that 5-HT7 receptors contribute to serotonin-mediated activation of HCN channels in
495
RTN neurons. Finally, we tested this by using the 5-HT7 specific antagonist SB258719, along
496
with the 5-HT7 receptor agonist LP-44.
497
19
498
We found that bath application of 5-CT (5 µM) increased chemoreceptor activity from 0.97 ±
499
0.37 Hz to 1.48 ± 0.41 Hz (T(12) = 7.02, p < 0.0001; Figs. 7A-B). This change in activity
500
(0.52 ± 0.07 Hz) was similar in magnitude to the serotonin response when KCNQ channels
501
were blocked (Fig. 4C). A second exposure to 5-CT, this time when HCN channels were
502
blocked with ZD7288, failed to significantly increase firing rate (with a rise of only 0.16 ±
503
0.05 Hz; F(4,27) = 7.83, p = 0.0003; Figs. 7A-B). Bath application of WAY100635 had no
504
effect on baseline activity (T(6) = 1.67, p = 0.1452) or firing-rate response to 5-CT (F(4,27) =
505
7.83, p = 0.0003; Fig. 7B), suggesting that 5-HT1A receptors do not exert direct or indirect
506
control (e.g., modulation of inhibitory input) over chemosensitive RTN neurons in vitro.
507
Application of a 5-HT7 receptor blocker (SB258719 10 µM) reduced the firing rate response
508
of RTN chemoreceptors to serotonin by approximately half (T(3) = 6.98 , p = 0.006, data not
509
illustrated)
510
Furthermore, the 5-HT7 agonist LP-44 (2 µM) induced a 0.77 ± 0.16 Hz increase in
511
chemoreceptor firing rate and this response was blocked by a 5-HT7 antagonist (SB258719;
512
10µM) (T(3) = 5.56, p = 0.0309; Fig. 7D).
513
receptors mediate the effects of serotonin on HCN channels in RTN neurons.
and
eliminated the 5-CT response (T(4) = 3.70, p =
0.0208; Fig. 7C).
Together, these results suggest that 5-HT7
514 515
DISCUSSION
516
The RTN is an important locus of respiratory control, as neurons in this region provide a
517
CO2/H+-dependent drive to breathe (Mulkey et al. 2004; Wang et al. 2013) and serve as a
518
point of convergence for other respiratory centers including the medullary raphe (Hawryluk
519
et al. 2012; Mulkey et al. 2007).
520
breathing, we are only just beginning to understand the ionic mechanisms that control their
521
resting membrane potential and response to neurotransmitters. Recent evidence indicates that
522
KCNQ channels in RTN neurons are key determinants of resting firing behavior and
Despite the importance of RTN chemoreceptors in
20
523
serotonergic modulation of breathing (Hawryluk et al. 2012). Here we show that HCN
524
channels are expressed in RTN chemoreceptor neurons and are a second essential regulator of
525
serotonin-mediated chemoreceptor function.
526
influence repetitive firing behavior of RTN chemoreceptors by depolarizing membrane
527
potential during hyperpolarization and shortening the rebound spike latency. We also show
528
that inhibition of HCN channels increased spontaneous activity, blunted serotonergic
529
modulation of RTN neurons in vitro, and attenuated the ventilatory response to serotonin in
530
vivo. The mechanism underlying serotonergic activation of HCN channels in RTN neurons
531
appears to involve adenylate cyclase activity and can be mimicked or blunted by drugs that
532
activate or block 5-HT7 receptors. Together with previous data, these results suggest that
533
serotonin regulates activity of RTN neurons by Gs-mediated activation of HCN channels and
534
Gq-mediated inhibition of KCNQ channels.
Specifically, we show that HCN channels
535 536
A limitation of our experimental approach is that our in vivo and in vitro conditions differ in
537
terms of animal age, temperature and CO2/H+ stimulus intensity. Age and temperature can
538
influence many physiological parameters including adenylate cyclase activity and HCN
539
channel kinetics, both of which are increased by warming from room to body temperature.
540
Therefore, it is possible that we underestimate the extent to which these channels contribute
541
to chemoreceptor activity. However, we have shown previously that chemosensitive RTN
542
neurons in slices from rat pups (recorded at room temperature) respond to raphe
543
neurotransmitters (e.g., serotonin) in a manner similar to chemosensitive RTN neurons in
544
anesthetized adult rats (Mulkey et al. 2007). Therefore, it is unlikely that fundamental
545
mechanisms underlying neurotransmitter modulation of these neurons (i.e., HCN channel
546
modulation) differs significantly with age or temperature. Although ZD7822 is a commonly
547
used HCN channel blocker, there is some evidence that it can also block Na+ and Ca2+
21
548
channels (Wu et al 2012). Therefore, to minimize potential off target effects, we also used a
549
second HCN channel block (Cs+) that chemically district and unlikely to produce common
550
off target effects. It should also be noted that Cd+2, in addition to blocking Ca2+-channels can
551
also block certain voltage-gated K+ channels (Abbruzzese et al., 2010). Therefore, additional
552
experiments are required to confirm involvement of Ca2+-channels. Lastly, we also
553
recognize that the level of CO2 used here to identify chemosensitive RTN neurons is high.
554
However, we consider this a minor issue because cells identified in vitro as chemoreceptors
555
using 15% CO2 appear to be of the same population of cells identified in vivo as RTN
556
chemoreceptors, i.e., located in the same region, are glutamatergic and express Phox2B
557
(Mulkey et al. 2004; Mulkey et al. 2007b)
558 559
HCN channels generate an inward current (Ih) at sub-threshold potentials that can have
560
opposing influences on neuronal excitability. For example, activation of Ih has been shown
561
to increase neuronal excitability by depolarizing membrane potential (Wenker et al. 2012a).
562
However, activation of Ih also inhibits neuronal activity by decreasing input resistance, as
563
well as by modulating activity of other voltage-dependent channels, e.g., Ih-mediated
564
depolarization can increase activity of KCNQ channels (George et al. 2009) and prolong
565
inactivation of Ca2+ channels (Tsay et al. 2007). Therefore, both activation and inhibition of
566
HCN channels may cause similar effects on neural activity. Furthermore, the net contribution
567
of Ih to RTN chemoreceptor activity likely depends on several factors including subcellular
568
HCN channel distribution and proximity to other voltage-gated ion channels and/or
569
neurotransmitter receptors. Here, we show in vitro that blocking HCN channels increased the
570
firing rate of RTN neurons under control conditions. Likewise, bilateral RTN injections of
571
ZD7288 increased basal respiratory activity in anesthetized rats. We also found in vitro that
572
the firing rate response of RTN chemoreceptors to HCN channel blockade was blunted by
22
573
XE991 and eliminated by Cd2+, suggesting that under resting conditions HCN channels limit
574
chemoreceptor activity by mechanisms involving KCNQ and Cd+2-sensitive channels
575
including Ca2+ channels. Consistent with a contribution of KCNQ channels to the inhibitory
576
effects of HCN channel blockade, we found in vivo that bilateral RTN injections of ZD7288
577
and XE991 increased respiratory output by an amount similar to either drug alone (i.e., the
578
responses were not additive). These results are consistent with evidence from other brain
579
regions that showed HCN-mediated depolarization can enhance activity of voltage-dependent
580
KCNQ channels and in doing so produced a net inhibitory influence on neuronal excitability
581
(George et al. 2009). An additional inhibitory effect of HCN channel activation has been
582
shown to result from prolonging Ca2+ channel inactivation (Tsay et al., 2007). Importantly,
583
the excitatory effect of serotonin on chemoreceptor activity was retained in Cd2+, as expected
584
for activation of an inward current. These results suggest that excitatory and inhibitory
585
effects of HCN channel activity can coexist in the same cells and can contribute to RTN
586
chemoreceptor activity by different mechanisms.
587 588
Serotonergic modulation of RTN chemoreceptor neurons appears to be intrinsic. For
589
example, previous (Mulkey et al. 2007a) and present results suggest that in the presence of
590
TTX (to block action potentials) RTN chemoreceptors respond to serotonin with a modest
591
decrease in holding current. Furthermore, we show here that RTN chemoreceptors exhibit a
592
characteristic Ih that was activated by serotonin, suggesting a direct effect of serotonin on
593
HCN channels in RTN chemoreceptors.
594
contribute to the mechanism of chemoreception (Gourine et al. 2010; Huckstepp et al. 2010;
595
Wenker et al. 2012), presumably by a TTX-independent mechanism, preliminary results
596
suggest that CO2/H+-sensitive RTN astrocytes do not exhibit a serotonin-sensitive current
597
(data not shown). However, there is some evidence that astrocytes in other brain regions
Although RTN astrocytes are also known to
23
598
express 5-HT receptors (Hirst et al. 1997; Miyazaki et al. 2013) and so it remains possible
599
that astrocytes influence serotonergic modulation of chemoreception at other levels of the
600
respiratory network.
601 602
The role we are attributing to HCN channels in chemosensitive RTN neurons differs from
603
that previously described for CO2-inhibited medullary neurons isolated from fetal rats, where
604
inhibition of HCN channels decreased resting activity and blocked CO2/H+-sensitivity
605
(Wellner-Kienitz and Shams 1998). The divergent roles of Ih in these cell types may be due
606
to developmental changes in the expression of HCN channel subunits as described in other
607
brainstem regions (Bayliss et al. 1994); however, this possibility requires further
608
investigation.
609 610
Our working model for serotonergic modulation of RTN chemoreceptor activity as
611
summarized in Figure 8. Ketanserin has been shown to block serotonin-stimulated activity of
612
RTN neurons (Mulkey et al. 2007), suggesting involvement of 5-HT2- and/or 5-HT7-
613
receptors. It is well known that 5-HT2 receptors are coupled to the phosphoinositol (i.e., Gq-
614
coupled) second messenger system, which can modulate ion channel function by depleting
615
plasma membrane levels of phosphatidylinositol 4,5-bisphosphate (PIP2) and by formation of
616
inositol 1,4,5-trisphosphate and diacylglycerol (Suh and Hille, 2002). Although not tested
617
directly in this study, it is likely that activation of 5-HT2 receptors and subsequent PIP2
618
depletion is the likely mechanism by which serotonin inhibits KCNQ channels in RTN
619
neurons (Hawryluk et al. 2012; Delmas and Brown 2005). It is also well established that 5-
620
HT7 receptors are coupled to trimeric Gs proteins and when activated stimulate adenylate
621
cyclase production of cAMP followed by activation of protein kinase A (PKA) (Matthys et
622
al. 2011).
We show that activation of HCN channels via this signaling pathway also
24
623
contributes to serotonergic modulation of RTN chemoreceptors. Although activation of each
624
of these pathways can independently increase neuronal activity, simultaneous activation of
625
both may antagonize downstream effects on KCNQ and HCN channels. For example, Gq-
626
mediated PIP2 depletion (Pian P et. al., 2006) and PKC activation (Lui et al., 2003) have been
627
shown to inhibit Ih whereas Gs-mediated activation of PKA may activate KCNQ channels in
628
smooth muscle cells (Simms et al. 1988). It is possible that coordinated activation of both Gs
629
and Gq cascades ensures a robust serotonin response, while cross-talk between pathways
630
prevents over-activation.
631 632
In summary, our data identify HCN channels as key determinants of both excitability and
633
serotonergic modulation of RTN chemoreceptor neurons and breathing. The mechanism by
634
which serotonin activates HCN channels in RTN chemoreceptor neurons involves Gs-
635
coupled receptor signaling via 5-HT7 receptors.
636 637
25
638
FIGURE LEGENDS
639
Figure 1.
640
ventilatory response to CO2 in anesthetized rats.
641
CO2 (etCO2), arterial pressure (AP) and integrated phrenic nerve discharge (iPND) show the
642
respiratory response to bilateral injections (arrows) of saline or HCN channel inhibitor
643
ZD7288 in the RTN. Under control conditions injections of ZD7288 (50 μM, 50 nl each
644
side) increased respiratory activity with an increase in mvPND (product of PND amplitude
645
and frequency) and significantly lowered PND CO2 threshold (D). However, CO2-
646
responsiveness was otherwise unaffected by application of ZD7288 in the RTN; lowering
647
etCO2 from to 3-4% inhibited respiratory output, and graded increases etCO2 up to 9-10%
648
increased mvPND by an amount similar to saline (control). B, Summary data plotted as
649
change in mvPND shows the effect of ZD7288 alone (50 μM) or in combination with KCNQ
650
channel inhibitor XE991 (50 μM) on resting respiratory activity (N= 7 animals). C, Summary
651
data showing CO2-induced changes in mvPND under control conditions, after injections of
652
ZD7288 or XE991 or after injections of ZD7288 + XE991 (N= 7 animals). D, Summary data
653
showing
654
level of CO2 required to stimulate PND activity (N= 7 animals). E, computer-assisted plots of
655
the center of the injection sites (coronal projection on the plane Bregma -11.6 and -11.3
656
mm; Paxinos and Watson 1989). Note that all injections were made in the caudal aspect of
657
the RTN where there is the highest density of chemosensitive RTN neurons. Abbreviations:
658
py, pyramids; Sp5, spinal trigeminal tract; VII, facial motor nucleus.
HCN channels in the RTN regulate resting breathing activity and the
that ZD7288
alone
or
in
combination
A, Traces of end expiratory
with
XE991
decreased
the
659 660
Figure 2.
661
respiratory drive in anesthetized rats. A1, traces of integrated phrenic nerve discharge
662
(iPND) and arterial pressure (AP) show effects of unilateral RTN injections of serotonin (5-
HCN channels in the RTN contribute to serotonergic modulation of
26
663
HT; 1 mM) on breathing and blood pressure under control conditions, after RTN injection of
664
XE991 (50 µM; A1) or ZD7288 (50 µM; A2) alone, and after injections of both XE991 and
665
the HCN channel blocker ZD7288 (A1). Inset, traces of iPND plotted on an expanded time
666
scale. Under control conditions RTN injection of serotonin increased PND amplitude and
667
decreased mean arterial pressure (MAP). Unilateral RTN injection of XE991 or ZD7288
668
decreased effects of serotonin on PND amplitude by ~40% and co-administration of ZD7288
669
with XE991 eliminated the serotonin response. Note the effect of serotonin on PND fully
670
recovered after 60 minutes. B, Computer-assisted plot shows the locations of injection sites
671
within the RTN (Bregma -11.6 mm). C, summary data (N = 6 animals) showing the effects
672
of serotonin on PND amplitude under control conditions, XE991 alone, ZD7288 alone and
673
XE991 plus ZD7288. *p < 0.05 versus control. Abbreviations: py, pyramids; RPa, raphe
674
pallidus; Sp5, spinal trigeminal tract; VII, facial motor nucleus.
675 676
Figure 3. Contributions of HCN and KCNQ channels to repetitive firing behavior of
677
chemosensitive RTN neurons. A1, membrane potential responses to a depolarizing step
678
(+20 pA) and hyperpolarizing current steps (-70 to -100pA, ∆10pA) under control conditions
679
and in ZD9288 (50µM, red). A2-A4, summary data (N=6) showing sag ratio (A2),
680
instantaneous spike frequency (ISF; A3) and rebound spike latency (A4) under control
681
conditions and in ZD7288. Note the characteristic HCN channel-dependent depolarizing sag
682
and short latency rebound spike. B1, voltage responses to a depolarizing step (+20 pA) and
683
hyperpolarizing current steps (-70 to -100pA, ∆10pA) under control conditions and in XE991
684
(10µM, blue). B2-B4, summary data (N=5) showing sag ratio (B2), ISF (B3) and rebound
685
spike latency (B4) under control conditions and in XE991 (10 µM, blue). Blocking KCNQ
686
channels increased ISF but did not affect the sag ratio or rebound spike latency.
27
687
Figure 4. HCN channels contribute to resting firing behavior and serotonergic
688
modulation of RTN chemoreceptors in vitro. A1, representative trace of firing rate from a
689
chemosensitive RTN neuron. Under control conditions exposure to serotonin (5-HT; 5 µM)
690
increased firing rate in a CO2 sensitive neuron. After washing out serotonin and returning to
691
a basal level of activity, bath application of XE991 (10 µM) also increased firing rate. In the
692
continued presence of XE991 (with baseline activity adjusted to near control levels by DC
693
current injection), a second exposure to serotonin only increased firing rate by approximately
694
half the control response.
695
firing rate by ~1 Hz. In the presence of XE991 plus ZD7288 (with baseline activity adjusted
696
to near control levels by DC current injection), a third exposure to serotonin had no
697
discernible effect on firing rate.
698
chemoreceptor to 5-HT and Cs+ under control conditions and in the presence of Cd2+ (100
699
µM). Note that Cd2+ eliminated the inhibitory effect of HCN channel blockade (reflected as
700
an increase in firing rate) but did not affect the serotonin response. B, summary data shows
701
the firing rate response of RTN chemoreceptors to HCN channel inhibition by ZD7288 or Cs+
702
(2 mM) under control conditions (N = 17 cells), in XE991 to block KCNQ channels (N = 12
703
cells), in synaptic blockers (N=7 cells), and in Cd2+ to block channels including voltage-gated
704
Ca2+ channels (N = 7 cells).
705
HCN channel inhibition. C, summary data shows the firing rate response to serotonin under
706
control conditions (N=16 cells), in XE991 alone (N = 13 cells), in ZD7288 alone (N = 4
707
cells) and in XE991 plus ZD7288 (N = 7 cells) or Cs2+ (2 mM; N = 6 cells). D, firing rate
708
trace shows that exposure to 15% CO2 increased activity of a chemosensitive RTN neuron by
709
similar amounts under control conditions and in the presence of ZD7288 (50 µM). E,
710
summary data (N = 6 cells) showing that CO2/H+-sensitivity of RTN neurons is fully retained
711
when HCN channels are blocked by ZD7288. F, summary data (N = 7 cells) shows that
Subsequent bath application of ZD7288 (50 µM) also increased
A2, firing rate trace shows the response of an RTN
Both XE991 and Cd2+ significantly reduced the responses to
28
712
serotonin responses were also retained during Ca2+ channel blockade. // marks 10 min time
713
breaks and ↓ indicates DC current injection. *p < 0.05, **p < 0.01, ***p < 0.001.
714 715
Figure 5. Serotonin activates HCN channels by a cAMP-dependent mechanism. A,
716
representative trace of firing rate from a chemosensitive RTN neuron. Under control
717
conditions exposure to serotonin (5-HT; 5 µM) increased firing in a CO2 sensitive neuron by
718
~1 Hz. After washout of serotonin, bath application of XE991 (10 µM) also increased firing
719
rate by ~1.2 Hz. In the continued presence of XE991 (with baseline activity adjusted to near
720
control levels by DC current injection), a second exposure to serotonin only increased firing
721
rate by ~0.5 Hz.
722
(100 µM) increased firing rate by ~0.8 Hz. In the presence of XE991 plus SQ22536 (with
723
baseline activity adjusted to near control levels by DC current injection), a third exposure to
724
serotonin no longer led to increased firing. B, summary data (N = 5 cells) of firing rate
725
responses to SQ22536 when KCNQ channels are blocked with XE991. C, summary data (N
726
= 5 cells) of firing rate responses to serotonin under control conditions, in XE991 alone and
727
in XE991 plus SQ22536. // marks 10 min time breaks and ↓ indicates DC current injection.
728
*p < 0.05, **p < 0.01.
Subsequent bath application of the adenylate cyclase inhibitor SQ22536
729 730
Figure 6.
731
Ih in RTN chemoreceptors. A, current responses to hyperpolarizing voltage steps recorded
732
under control conditions (A1), in serotonin (5 µM, A2), after washing serotonin for 5 min
733
(A3), and in ZD7288 (50 µM). Note that serotonin caused a modest decrease in holding
734
current (arrows indicate zero current levels). B, summary data (N=6 cells/ animals) showing
735
that serotonin did not increase maximal Ih amplitude, measured as the difference between
736
steady state and instantaneous currents at -150 mV (illustrated in A1). C, Ih activation curves
Serotonin causes a depolarizing shift in the voltage-dependent activation of
29
737
where tail currents were measured during a fixed step to -70 mV that followed each test pulse
738
(asterisks in A) and normalized data was fitted using the Boltzmann equation, under control
739
conditions and in serotonin. Serotonin causes a depolarizing shift in the voltage-dependent
740
activation of Ih (V1/2 values inset, N = 7). *p < 0.05, **p < 0.01.
741 742
Figure 7.
743
chemoreceptors. A, representative trace of firing rate from a chemosensitive RTN neuron
744
shows that under control conditions exposure to 5-carboxamidotryptamine (5-CT; 5 µM)
745
increased firing by ~0.4 Hz. As before, bath application of ZD7288 (50 µM) also increased
746
firing rate. A second exposure to 5-CT, this time in the presence of ZD7288 (with baseline
747
activity adjusted to near control levels by DC current injection), had no effect on firing rate.
748
B, trace of firing rate shows the response of an RTN chemoreceptor to 5-CT was blocked by
749
10 minute incubation in SB258719 (10 µM), a 5-HT7 receptor blocker. C, summary data (N
750
≥4 cells) showing the firing rate response to 5-CT under control conditions and in the
751
presence of ZD7288 alone, the 5-HT1A receptor antagonist WAY100635 (0.1µM) alone, or
752
the 5-HT7 receptor antagonist SB258719. Note that WAY100635 did not affect the response
753
to 5-CT, suggesting 5-HT1A receptors do not contribute to this response whereas 5-HT7
754
inhibition significantly reduced the serotonin response. D, average data (N = 3 cells) showing
755
the firing rate response of RTN chemoreceptors the 5-HT7 receptor agonist LP-44 (2µM)
756
under control conditions and in the presence of the 5-HT7 receptor antagonist SB258719. //
757
designates 10 min time breaks and ↓ indicates DC current injection. *p < 0.05, **p < 0.01,
758
***p < 0.001.
5-HT7 receptor activation mediates effects of serotonin
on RTN
759 760
Figure 8. Model depicting the molecular basis for serotonergic modulation of RTN
761
chemoreceptors.
Previous (Hawryluk et al., 2012) and present results show that serotonin
30
762
stimulates activity of RTN chemoreceptors by two independent but coordinated signaling
763
pathways: 5-HT2 mediated inhibition of KCNQ channels most likely by Gq signaling, and 5-
764
HT7-medaited activation of HCN channels by a mechanism involving activation of adenylate
765
cyclase and cAMP mediated depolarizing shift in the voltage-dependent activation of Ih. Our
766
evidence suggests that each of these signaling pathways can independently stimulate activity
767
of RTN chemoreceptors, and together their coordinated activity ensures a robust response to
768
serotonin. Note that our evidence also suggests that under basal conditions HCN channel
769
activity may indirectly modulate activity of voltage-dependent KCNQ and Cd+2-sensitive
770
channels including Ca2+ channels.
771
31
772
References
773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820
Abbruzzese J, Sachse FB, Tristani-Firouzi M, Sanguinetti MC. Modification of hERG1 channel gating by Cd2+. J Gen Physiol. 136:203-24, 2010. Bayliss DA, Viana F, Bellingham MC, Berger AJ. Characteristics and postnatal development of a hyperpolarization-activated inward current in rat hypoglossal motoneurons in vitro. J Neurophysiol 71:119-128, 1994. Beique JC, Campbell B, Perring P, Hamblin MW, Walker P, Mladenovic L and Andrade R. Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. J Neurosci 24:4807-4817, 2004. Brown DL and Guyenet PG. Electrophysiological study of cardiovascular neurons in the rostral ventrolateral medulla in rats. Circ Res 56, 359-369, 1985. Buchanan GF, Murray NM, Hajek MA, Richerson GB. Serotonin neurons have anticonvulsant effects and reduce seizure-induced mortality. J Physiol 592:4395-410, 2014. Corcoran AE, Commons KG, Wu Y, Smith JC, Harris MB, Richerson GB. Dual effects of 5-HT(1a) receptor activation on breathing in neonatal mice. J Neurosci 34:51-9, 2014. Delmas P, Brown DA. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci. 6:850-62, 2005. DiFrancesco D and Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 351:145-7, 1991. Fenik P and Veasey SC. Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus. Am J Respir Crit Care Med 167:563-569, 2003. George MS, Abbott LF and Siegelbaum SA. HCN hyperpolarization-activated cation channels inhibit EPSPs by interactions with M-type K(+) channels. Nat Neurosci 12:577-584, 2009. Gourine AV, Kasymov V, Marina N, Tang F, Figueiredo MF, Lane S, Teschemacher AG, Spyer KM, Deisseroth K and Kasparov S. Astrocytes control breathing through pHdependent release of ATP. Science 329:571-575, 2010. Hawryluk JM, Moreira TS, Takakura AC, Wenker IC, Tzingounis AV, and Mulkey DK. KCNQ channels determine serotonergic modulation of ventral surface chemoreceptors and respiratory drive. J Neurosci 32:16943-16952, 2012. Hirst WD, Price GW, Rattray M, Wilkin GP. Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes. Br J Pharmacol 120:509-15, 1997 Hodges MR, Tattersall GJ, Harris MB, McEvoy SD, Richerson DN, Deneris ES, Johnson RL, Chen ZF and Richerson GB. Defects in breathing and thermoregulation in 32
821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868
mice with near-complete absence of central serotonin neurons. J Neurosci 28:2495-2505, 2008. Huckstepp RT, id BR, Eason R, Spyer KM, Dicke N, Willecke K, Marina N, Gourine AV and Dale N. Connexin hemichannel-mediated CO2-dependent release of ATP in the medulla oblongata contributes to central respiratory chemosensitivity. J Physiol 588:39013920, 2010. Jasper JR, Kosaka A, To ZP, Chang DJ and Eglen RM. Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b). Br J Pharmacol 122:126-132, 1997. Kang BJ, Chang DA, Mackay DD, West GH, Moreira TS, Takakura AC, Gwilt JM, Guyenet PG and Stornetta RL. Central nervous system distribution of the transcription factor Phox2b in the adult rat. J Comp Neurol 503:627-641, 2007. Lazarenko RM, Milner TA, Depuy SD, Stornetta RL, West GH, Kievits JA, Bayliss DA and Guyenet PG. Acid sensitivity and ultrastructure of the retrotrapezoid nucleus in Phox2b-EGFP transgenic mice. J Comp Neurol 517, 69-86, 2009. Lesage AS, Wouters R, Van Gompel P, Heylen L, Vanhoenacker P, Haegeman G, Luyten WH and Leysen JE. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines. Br J Pharmacol 123:1655-65, 1998. Liu Z, Bunney EB, Appel SB, Brodie MS. Serotonin reduces the hyperpolarizationactivated current (Ih) in ventral tegmental area dopamine neurons: involvement of 5-HT2 receptors and protein kinase C. J Neurophysiol 90:3201-12, 2003. Massey CA, Sowers LP, Dlouhy BJ, Richerson GB. Mechanisms of sudden unexpected death in epilepsy: the pathway to prevention. Nature Reviews Neurology 10:271-282, 2014. Matthys A, Haegeman G, Van CK and Vanhoenacker P. Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. Mol Neurobiol 43:228253, 2011. Miyazaki I, Asanuma M, Murakami S, Takeshima M, Torigoe N, Kitamura Y, Miyoshi K. Targeting 5-HT(1A) receptors in astrocytes to protect dopaminergic neurons in Parkinsonian models. Neurobiol Dis 59:244-56, 2013. Mulkey DK, Mistry AM, Guyenet PG and Bayliss DA. Purinergic P2 receptors modulate excitability but do not mediate pH sensitivity of RTN respiratory chemoreceptors. J Neurosci 26:7230-7233, 2006. Mulkey DK, Rosin DL, West G, Takakura AC, Moreira TS, Bayliss DA and Guyenet PG. Serotonergic neurons activate chemosensitive retrotrapezoid nucleus neurons by a pHindependent mechanism. J Neurosci 27:14128-14138, 2007a.
33
869 870 871 872 873 874 875 876 877 878 879 880 881 882 883
Mulkey DK, Talley EM, Stornetta RL, Siegel AR, West GH, Chen X, Sen N, Mistry AM, Guyenet PG and Bayliss DA. TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity. J Neurosci 27:14049-58, 2007b.
884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917
Ray RS, Corcoran AE, Brust RD, Kim JC, Richerson GB, Nattie E and Dymecki SM. Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition. Science 333:637-642, 2011.
Mulkey DK, Stornetta RL, Weston MC, Simmons JR, Parker A, Bayliss DA and Guyenet PG. Respiratory control by ventral surface chemoreceptor neurons in rats. Nat Neurosci 7:1360-1369, 2004. Paxinos G and Watson C. The rat brain in stereotaxic corrdiantes, 4ed. Academic Press, San Diego, 1989. Pian P, Bucchi A, Robinson RB, Siegelbaum SA. Regulation of gating and rundown of HCN hyperpolarization-activated channels by exogenous and endogenous PIP2. J Gen Physiol 128:593-604, 2006.
Richerson GB. Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat Rev Neurosci 5:449-461, 2004. Richter DW, Manzke T, Wilken B, Ponimaskin E. Serotonin receptors: Guardians of stable breathing. TRENDS in Mol Med 9:542-548, 2003. Ritucci NA, Erlichman JS, Leiter JC and Putnam RW. Response of membrane potential and intracellular pH to hypercapnia in neurons and astrocytes from rat retrotrapezoid nucleus. Am J Physiol Regul Integr Comp Physiol 289:R851-R861, 2005. Shen Y, Monsma FJ, Metcalf MA, Jose PA, Hamblin MW and Sibley DR. Molecular cloning and expression of 5-hydroxytryptamine7 serotonin receptors subtype. J Biol Chem 268:18200-204, 1993. Sirois JE, Lynch C, III and Bayliss DA. Convergent and reciprocal modulation of a leak K+ current and I(h) by an inhalational anaesthetic and neurotransmitters in rat brainstem motoneurones. J Physiol 541:717-729, 2002. Stornetta RL, Moreira TS, Takakura AC, Kang BJ, Chang DA, West GH, Brunet JF, Mulkey DK, Bayliss DA and Guyenet PG. Expression of Phox2b by brainstem neurons involved in chemosensory integration in the adult rat. J Neurosci 26:10305-10314, 2006. Stuart G and Spruston N. Determinants of voltage attenuation in neocortical pyramidal neuron dendrites. J Neurosci 18:3501-3510, 1998.
Suh BC, Hille B. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35:507-20, 2002
34
918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957
Takakura AC, Colombari E, Menani JV and Moreira TS. Ventrolateral medulla mechanisms involved in cardiorespiratory responses to central chemoreceptor activation in rats. Am J Physiol Regul Integr Comp Physiol 300:R501-R510, 2011. Takakura AC and Moreira TS. Contribution of excitatory amino acid receptors of the retrotrapezoid nucleus to the sympathetic chemoreflex in rats. Exp Physiol 96:989-999, 2011. Synaptically Tsay D, Dudman JT, and Siegelbaum SA. HCN1 channels constrain synaptically evoked Ca2+ spikes in distal dendrites of CA1 pyramidal neurons. Neuron 56:1076-89, 2007. Ulens C and Tytgat J. Gi- and Gs-coupled receptors up-regulate the cAMP cascade to modulate HCN2, but not HCN1 pacemaker channels. Pflugers Arch. 442:928-42, 2001. Wang S, Shi Y, Shu S, Guyenet PG and Bayliss DA. Phox2b-expressing retrotrapezoid neurons are intrinsically responsive to H+ and CO2. J Neurosci 33:7756-7761, 2013. Wellner-Kienitz MC and Shams H. Hyperpolarization-activated inward currents contribute to spontaneous electrical activity and CO2/H+ sensitivity of cultivated neurons of fetal rat medulla. Neuroscience 87:109-121, 1998. Wenker IC, Benoit JP, Chen X, Liu H, Horner RL and Mulkey DK. Nitric oxide activates hypoglossal motoneurons by cGMP-dependent inhibition of TASK channels and cGMP-independent activation of HCN channels. J Neurophysiol 107:1489-1499, 2012a. Wenker IC, Kreneisz O, Nishiyama A and Mulkey DK. Astrocytes in the retrotrapezoid nucleus sense H+ by inhibition of a Kir4.1-Kir5.1-like current and may contribute to chemoreception by a purinergic mechanism. J Neurophysiol 104:3042-3052, 2010. Wenker IC, Sobrinho CR, Takakura AC, Moreira TS and Mulkey DK. Regulation of ventral surface CO2/H+-sensitive neurons by purinergic signaling. J Physiol 590:2137-2150, 2012b. Wettschureck N and Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol Rev 85:1159-1204, 2005. Wu X, Liao L, Liu X, Luo F, Yang T, Li C. Is ZD7288 a selective blocker of hyperpolarization-activated cyclic nucleotide-gated channel currents? Channels 6:438-42, 2012.
35
$
HW&2
$3 PP+J
V
VDOLQH
='
L31'
&
'
&2LQGXFHG ǻPY31'
ǻUHVWLQJ PY31'
%
V
31'WKUHVKROG &2
L31' DX
(
VDOLQHVDOLQH VDOLQH=' ;(VDOLQH ;(='
6S
PP
9,,
S\
)LJXUH
PP 571
;(
$
+7
+7
;( ='
%
+7
+7
6S
L31' DX
PLQ
9,,
53D S\
$3 PP+J
571
PLQ
FRQWURO DIWHU;(DORQH DIWHU='DORQH DIWHU;(='
L31'
V
=' +7
&
+7
L31' DX
$3 PP+J
+7ǻ31' DPSOLWXGH DERYHUHVWLQJ
$
PLQ
)LJXUH
% %
&RQ ='
&RQ ;(
)LJXUH
UHERXQGVSLNH ODWHQF\ PVHF
$
%
UHERXQGVSLNH ODWHQF\ PVHF
,6)+]
$
,6)+]
VDJUDWLR
P9
PV
VDJUDWLR
$ $
%
;(
$
)LULQJ5DWH +]
&2
=' +7
+7
+7
PLQ
&G
)LULQJ5DWH +]
&2
&V
+7
&V
+7
PLQ
&
16
&G
'
6%
;(
&2ǻ ILULQJUDWH+]
&2
16
RQ &
G &
RQ
)LJXUH
)
16
='
PLQ
&
(
ILULQJUDWH +]
&2
=' &2
&RQ ;(DORQH ='DORQH ='LQ;( LQ;( &V
&RQ
+&1FKDQQHOEORFN ǻILULQJUDWH+]
%
+7ǻ ILULQJUDWH+]
+7ǻ ILULQJUDWH+]
$
$
;(
&2
64
+7
+7
+7
PLQ
%
&
+7LQGXFHG ǻ)LULQJUDWH+]
ILULQJUDWH+]
)LULQJ5DWH+]
&RQ ;( 64 LQ;(
)LJXUH
$
$
FRQWURO
+7
$
$
ZDVK
='
S$
,K
PV
,KDFWLYDWLRQ
=' 7 + Q FR
P9
&
,KDPSOLWXGH DWP9 S$
%
9
)LJXUH
FRQ +7
P9
$ )LULQJ5DWH+]
='
&2 &7
&7
PLQ
6%
&2
&7
&7
PLQ
&7LQGXFHG ǻILULQJUDWH+]
&
'
/3LQGXFHG ǻILULQJUDWH+]
)LULQJ5DWH+]
%
6%
6%
$< :
RQ
='
&
)LJXUH
/3
6HURWRQLQ
+7
*V *T
$&
F$03
GHSRO .&14
+7
+&1
FKHPRVHQVLWLYH 571QHXURQ &GVHQVLWLYH
FKDQQHO
KLJK
ORZ
5HVSLUDWRU\'ULYH )LJXUH